New evidence strengthens link between vitamin E acetate, vaping illness
There have been 2,506 people hospitalized with EVALI across all 50 states, Washington, D.C, Puerto Rico, and the U.S. Virgin Islands.
Related Articles
The NIH puts a further chokehold on universities, and Ireland braces for pharma tariffs
And other health news stories you need to start your week.
FDA approves blockbuster Dupixent for chronic hives
And other biotech news updates brought to you by The Readout.
NIH moving to ban all future grants to universities with DEI programs or Israel boycotts, document suggests
NIH appears to be preparing to prohibit the awarding of new grants to institutions that have DEI programs or boycott Israeli companies
ACA marketplace worries, and a UNH stock chart
Affordable Care Act insurance enrollment may drop, UnitedHealth stumbles, and Braidwood arguments.
Intensive lowering of blood pressure tied to lower dementia risk
Intensive blood pressure control may cut dementia risk by 15%, says a new study in which community health workers managed hypertension treatment.
When should six drugs count as one? The answer could be a big deal for pharma companies
A unique Novo Nordisk legal challenge to the Medicare drug pricing program could have big implications for the pharma industry.
Pharmalittle: We’re reading about a Novo challenge to Medicare talks, a scuttled FDA office, and more
Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the same active ingredient.
Find COVID-19 guidance for your community
Official websites use .gov A.gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock () or…
Gilead says its therapy delayed growth of tumors in aggressive form of breast cancer
Gilead Sciences said a combination of its cancer drug Trodelvy and Merck’s Keytruda delayed the growth of tumors in women with a less common, but…
Immunovant replaces CEO, makes other changes as Roivant tightens control
The biotech company Immunovant announced changes to its management team, including the naming of a new chief executive, intended to give its majority owner greater…